Please assess the completion status of the following clinical trial:

Trial Title: RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* VATS~* ASA 1,2 or 3~* Minimum weight of 50 kg~* Patient able to consent~Exclusion Criteria:~* Patient refusal~* Patient unable to understand PCA~* Contraindication to rachianalgesia~* Zona~* Pregnancy~* Over 30 mg of morphine during the last 24 hours~* Use of Pregabalin, Gabapentin, Doluxetin, Amitriptyline or NSAI in a context of chronic pain~* Severe allergic reaction to morphine, hydromorphone, sufentanil or local anesthetic~* Intubation over 1 hour after surgery (unability to use PCA)~* High risk of conversion to thoracotomy~* Unable to perform rachianalgesia due to technical difficulties

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Intrathecal Morphine/Sufentanil and PCA (Type: ACTIVE_COMPARATOR): Patients will receive an intrathecal injection of Morphine 250 mcg and Sufentanil 10 mcg before the induction of anesthesia. They will have a PCA for analgesia rescue in the post-operative period.
- PCA alone (Type: PLACEBO_COMPARATOR): Patients will NOT receive an intrathecal injection of Morphine 250 mcg and Sufentanil 10 mcg before the induction of anesthesia. They will only have a PCA for analgesia in the post-operative period.

Based on this trial design, predict the completion outcome and termination type (if applicable).